BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29303290)

  • 1. [Non-small cell lung cancer].
    Skřičková J; Kadlec B; Venclíček O
    Vnitr Lek; 2018; 63(11):861-874. PubMed ID: 29303290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer.
    Skřičková J; Kadlec B; Venclíček O; Merta Z
    Cas Lek Cesk; 2018; 157(5):226-236. PubMed ID: 30441934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for non-small cell lung cancer.
    Evans WK
    Chest; 1989 Jul; 96(1 Suppl):87S-91S. PubMed ID: 2544378
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant Therapy in Non-Small Cell Lung Cancer.
    Zheng Y; Jaklitsch MT; Bueno R
    Surg Oncol Clin N Am; 2016 Jul; 25(3):567-84. PubMed ID: 27261916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of N2 non-small cell lung cancer (NSCLC).
    Klastersky J; Feld R; Kleisbauer JP; Rocmans P
    Chest; 1989 Jul; 96(1 Suppl):83S-85S. PubMed ID: 2544376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Data from the AACR 2018 meeting on the combination chimio-immunotherapy on advanced non-small cells lung cancer (NSCLC)].
    Simonneau Y; Ruppert AM; Chaabane N; Lavolé A; Wislez M
    Bull Cancer; 2018 Oct; 105(10):854-856. PubMed ID: 30262415
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolving locally-advanced non-small cell lung cancer landscape: Building on past evidence and experience.
    Méry B; Guy JB; Swalduz A; Vallard A; Guibert C; Almokhles H; Ben Mrad M; Rivoirard R; Falk AT; Fournel P; Magné N
    Crit Rev Oncol Hematol; 2015 Nov; 96(2):319-27. PubMed ID: 26095618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.
    Antoni D; Mornex F
    Curr Opin Oncol; 2016 Mar; 28(2):104-9. PubMed ID: 26848885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative therapy for locoregional nonsmall-cell lung cancer.
    Takita H
    J Surg Oncol; 1996 May; 62(1):65-74. PubMed ID: 8618405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer.
    Uprety D
    Clin Lung Cancer; 2019 Mar; 20(2):63-65. PubMed ID: 30545572
    [No Abstract]   [Full Text] [Related]  

  • 13. Combining Immunotherapy with Radiation Therapy in Non-Small Cell Lung Cancer.
    Fitzgerald K; Simone CB
    Thorac Surg Clin; 2020 May; 30(2):221-239. PubMed ID: 32327181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent issues in the treatment of advanced non-small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine immunotherapy in lung cancer: Clinical experience and future directions.
    Freeman-Keller M; Goldman J; Gray J
    Pharmacol Ther; 2015 Sep; 153():1-9. PubMed ID: 25989231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant and adjuvant therapy of non-small cell lung cancer.
    Rose LJ
    Semin Oncol; 1991 Dec; 18(6):536-42. PubMed ID: 1663661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer.
    Huber RM; Reck M; Thomas M
    Eur Respir J; 2013 Oct; 42(4):1119-33. PubMed ID: 23429914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options in stage III non-small cell lung cancer.
    Paraschiv B; Diaconu CC; Dumitrache-Rujinski S; Belaconi IN; Constantinescu T; Stroescu CC; Dantes E; Fildan AP; Bogdan MA; Toma CL
    Pneumologia; 2016; 65(2):67-70. PubMed ID: 29538961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.